NEW QIAstat-Dx Respiratory 2019-nCoV Panel 

NEW QIAstat-Dx Respiratory 2019-nCoV Panel 

Molecular Diagnostics

December 18, 2020

To support the research efforts for accessible testing to meet the demands of the COVID-19 outbreak, QIAGEN® developed the QIAstat-Dx® Respiratory 2019-nCoV Panel. This version of our multiplex syndromic cartridge detects and differentiates 22 respiratory targets, including 2019-nCoV (SARS-CoV-2).

  • Includes 2 molecular targets specific to 2019-nCoV: ORF1b gene recommended by the Chinese Center for Disease Control and Prevention, and the E gene recommended by the US Centers for Disease Control and Prevention
  • Less than 1 minute hands-on time
  • Time to result: approximately 1 hour
Cytokine storm in COVID-19 research

Cytokine storm in COVID-19 research

Molecular Diagnostics

New research is rapidly accumulating around cytokine storms as a key biological response to SARS-CoV-2 infection. Get more information and learn about products associated with this process.

May 05, 2020 More +
New QIAseq miRNA Library Kit overcomes miRNA-seq challenges

New QIAseq miRNA Library Kit overcomes miRNA-seq challenges

Molecular Diagnostics

microRNA sequencing is the future of gene regulation analysis, providing unmatched specificity for closely related microRNAs as well as the ability to detect novel noncoding transcripts. But challenges in the current workflow can cause up to half of microRNA sequencing data to be missed entirely.

 

January 04, 2017 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us